sh

s

ss



s4

s5

s6

s7

s8

s9

s10

s11

s12

s13
sssssssssssssss
ss
ss

Clinical Trials

Early intervention for childhood hypermetropia
This clinical trial is enrolling farsighted children between the ages of 6 months and 24 months who do not have strabismus (eye crossing) or amblyopia (decreased vision in one eye, sometimes called "lazy eye"). Eligible participants are randomly assigned to either glasses treatment or close observation, with follow-up every six months until the age of 3 1/2 years, unless strabismus or amblyopia develops before this time-point.

Collaboration with craniofacial research
The Vision Development Institute is partnering with craniofacial experts in the Childrens Hospital Los Angeles Division of Plastic Surgery, led by Mark M. Urata, MD, DDS, on studies looking at the impact of disorders such as craniosyntosis on visual development.